Results

1–10 of 35 results for Uveal melanoma

Gene Expression Profile and Local Tumor Recurrence of Irradiated Uveal Melanomas
Basil K Williams, MD
Annual Meeting Talks
2022
Prospective Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: One-Year Outcomes
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2022
Incidence of Uveal Melanoma in Kaiser Permanante Northern California
On Demand Cases, Courses, and Papers
2022
Current Status of “Liquid Biopsy” for Uveal Melanoma
Ivana K. Kim, MD
Updates from the Field
2022
A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma
Prithvi Mruthyunjaya, MD, MHS
Annual Meeting Talks
2021
Comparison of Tumor Size at Presentation and Genomics in Uveal Melanoma Patients Before and After the COVID-19 Pandemic
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2021
Gene Expression Profile and Local Tumor Recurrence of Irradiated Uveal Melanomas
Basil K Williams, MD
Updates from the Field
2022
Impact of PRAME Status on Gene Expression Profile to Predict Metastasis in Uveal Melanoma: Interim Analysis of the Collaborative Ocular Oncology Group Study Number 2 (COOG2)
Prithvi Mruthyunjaya, MD, MHS
Updates from the Field
2022
Incidence and features of uveal melanoma in a closed, managed care population
Michael Seider, MD
On Demand Cases, Courses, and Papers
2019
Eye Physics (EP) Plaques for Uveal Melanoma: Initial 12- and 24-month results in a private practice setting performed by a young surgeon
David A Reichstein, MD
On Demand Cases, Courses, and Papers
2019